# KUNLUN

> KUNLUN is a VC fund in Beijing backing E-Commerce and Internet. See 44 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Beijing, China
- Total investments: 44
- Last investment: Jul 2026
- Lead investor: 34%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/kunlun-inc/
- Website: http://www.kunlun.com

Kunlun is an internet group that is dedicated to the development of interactive platforms and applications for global user groups. Kunlun's buseiness includes GameArk and Opera. GameArk focus on internet gaming and Opera focus on global internet. Kunlun has two public companies, Kunlun Tech Co listed SHE: 300418 and Opera Ltd listed NASDAQ:OPRA. Kunlun Capital is the investment arm of Kunlun Group, which focuses on venture investment globally.

## Contacts

5 contacts available for KUNLUN. Shizune tracks 3 team members at KUNLUN. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/kunlun?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $1.4M–$50M |
| Series B | $2.8M–$462M |
| Series C | $11M–$134M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| E-Commerce | 7 | 16% |
| Internet | 5 | 11% |
| FinTech | 4 | 9% |
| Software | 4 | 9% |
| Biotechnology | 4 | 9% |

78 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 11 | 25% |
| Series A | 9 | 20% |
| Series C | 8 | 18% |
| Series D | 5 | 11% |
| Venture - Series Unknown | 4 | 9% |

10 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| China | 28 | 64% |
| United States | 6 | 14% |
| India | 1 | 2% |
| Israel | 1 | 2% |
| Nigeria | 1 | 2% |

7 countries tracked in total.

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jecci Yao | Director of Marketing and Communications | 0 | https://shizune.co/investors/profile/jecci-yao |
| James Yahui | CEO | 1 | https://shizune.co/investors/profile/yahui-zhou |
| Liwei Wang | General Manager | 0 | https://shizune.co/investors/profile/liwei-wang-8798 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Riemann Dynamics | Riemann Dynamics is a high-tech enterprise specializing in the research and development of advanced robot manipulation models, leveraging artificial intelligence and robotics technologies to enable robots to perform complex tasks with greater precision, adaptability, and autonomy across industrial automation, logistics, manufacturing, and otherintelligent applications. |  | Seed | Jul 20, 2026 |  |
| Microquanta | Hangzhou-based Microquanta (MQS) is a maker of perovskite solar cell, which is a new form of solar technology that holds promises of delivering more electricity but at notably lower costs. According to the company, its latest perovskite mini-module has an electricity conversion rate of 17%, beating its previous record of 16%. So far, MQS has raised$10 million in total funding to further commercialize the technology, expecting to find production lines this year. |  | Series D | Oct 09, 2022 | http://www.microquanta.com/gywm |
| StarMaker Interactive | StarMaker is an online video network whose mission is to move content creation and talent discovery from traditional media to the mobile and social space. Combining the power of content creation apps, recording studio technology, crowd-sourced talent discovery, and a huge network of user channels on YouTube, StarMaker's platform enablesartists to manage their career without the antiquated Entertainment Industry waste. StarMaker also integrates major media brands and recording artists, helping their talent create, share, discover, and promote each other's user-generated media. | $83.5M | Secondary Market | Apr 21, 2022 | http://starmakerstudios.com |
| Yudao Bio | Yudo Bio provides biopharmaceutical products. It has its headquarters in Shanghai in China. | $40M | Series A | Mar 14, 2022 | http://www.ucdom.cn/ |
| UniXell Biotechnology | Yuesai Biotechnology is a new-generation cell therapy drug developer, focusing on the development of a new generation of cell therapy drugs. | $31.4M | Seed | Mar 14, 2022 |  |
| Kopi Kenangan | Kopi Kenangan is one of several grab-and-go coffee chains trying to capitalize on the rising trend and demand for grounded coffee beverages in a country which has the lowest coffee consumption per capita in the region, despite being the world’s fourth-largest coffee exporter. | $96M | Series C | Dec 27, 2021 | https://kopikenangan.com/ |
| YouWorld | YouWorld works with global banking partners and Financials Institutions to create a new global banking experiences for customers around the world. The company works with cross-border platforms such as WeChat and AliPay, as well as a network of travel and lifestyle apps, to deliver curated brand content and innovates traditional cross-border paymentrails by connecting global wallets and cards to create a market worth over $800 billion. Its lead product, the YouWorld Service Platform (YWSP), provides an integrating global digital banking that enables users to connect to their local mobile wallets and currency accounts and to shop globally with a rewards and buy-now-pay-later service. The company's huge user base also contributes a data tracking system that harnesses the reach of YouWorld’s omnichannel partners to drive foot traffic to brick-and-mortar retail and tourism businesses. The company was founded in 2016 and has offices in Pasadena, California and Shenzhen, China. | $5.5M | Series A | Sep 28, 2021 | https://www.you.world/ |
| CellOrigin Biotech | CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics. |  | Venture - Series Unknown | Jul 20, 2021 | http://en.cell-origin.com/ |
| Biotheus | Biotheus is an up-and-coming biotech company focused on curing malignant tumors and autoimmune diseases. Biotheus is committed to research and development, and commercialization of first-class innovative biologics mainly through the discovery of next-generation multispecific antibodies. | $100M | Series D | Mar 02, 2021 | http://www.biotheus.com |
| Synlight Crystal | Synlight Crystal achieves mass production of the 3rd generation semiconductor material SiC single crystal substrate. |  | Series B | Dec 29, 2020 | http://www.synlight.cn/index.php |

10 of 44 investments shown.

## Co-investors
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund, 6 deals together
- [HSG](https://shizune.co/investors/profile/hsg-cap) — VC Fund, 4 deals together
- [Source Code Capital](https://shizune.co/investors/profile/source-code-capital) — VC Fund, 4 deals together
- [GGV Capital](https://shizune.co/investors/profile/ggv-capital) — VC Fund, 3 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 3 deals together
- [Arrive](https://shizune.co/investors/profile/arrive-361a) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Goodwater Capital](https://shizune.co/investors/profile/goodwater-capital) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Ventures Platform](https://shizune.co/investors/profile/ventures-platform) — VC Fund
- [Microtraction](https://shizune.co/investors/profile/microtraction) — VC Fund
- [LoftyInc Capital](https://shizune.co/investors/profile/loftyinc-capital-management) — VC Fund

## Featured in investor lists
- [Mobile Apps Investors in Nigeria](https://shizune.co/investors/mobile-apps-investors-nigeria)
- [Mobile Apps VC Funds in Nigeria](https://shizune.co/investors/mobile-apps-vc-funds-nigeria)

## FAQ

### What does KUNLUN invest in?

KUNLUN invests primarily in E-Commerce, Internet and FinTech startups, most often at Series B and Series A stage. Most of the 44 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is KUNLUN's check size?

KUNLUN typically joins rounds of $1.4M–$50M at Series A, $2.8M–$462M at Series B and $11M–$134M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds KUNLUN participates in.

### How do I contact KUNLUN?

Public channels for KUNLUN include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at KUNLUN?

The team at KUNLUN includes Jecci Yao (Director of Marketing and Communications), James Yahui (CEO) and Liwei Wang (General Manager). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co